The Latest
-
Supreme Court hears challenge to Colorado’s ban on conversion therapy
The plaintiffs argue that speech in certain healthcare settings ought to be protected by the First Amendment. Critics say that sets a dangerous precedent, where providers can offer debunked or harmful medical advice with impunity.
-
shutterstock.com/Cinemato
Sponsored by ECHOPayment fraud in healthcare is getting harder to detect. Here’s how to fight back.
Fraudsters are raising the stakes. Explore why they’re harder to catch and how to strengthen your defenses across every claim payment.
-
Qualtrics to acquire healthcare market research firm Press Ganey for $6.75B
The deal gives the customer experience company access to Press Ganey’s extensive healthcare data to bolster artificial intelligence capabilities.
-
No Surprises dispute resolution remains operational despite shutdown
However, a prolonged lapse in funding could affect other activities underpinning implementation of the law that holds consumers blameless for unexpected out-of-network bills.
-
Top healthcare conferences to attend in 2026
These are the events healthcare leaders should plan for next year, covering topics like digital health, rural care and financial management.
-
Shareholder group calls on UnitedHealth to decouple CEO from board chair
Stephen Hemsley is the chairman of UnitedHealth’s board and its CEO. The Accountability Board says that undercuts corporate governance at a turbulent time for the company.
-
Deep Dive
AI could transform healthcare. Can safety-net providers keep up?
Implementing artificial intelligence requires significant human labor and technical expertise, threatening to create a digital divide between highly resourced health systems and safety-net providers.
-
Medicaid enrollees at risk of disenrollment report multiple chronic conditions: study
About 41% of beneficiaries who could lose coverage due to federal work requirements signed into law this summer have three or more chronic conditions, according to new JAMA research.
-
UnitedHealthcare, Humana, Aetna scale back Medicare Advantage plans for 2026
The coverage landscape for the privatized Medicare plans will look significantly different next year, giving smaller players a chance to snap up market share but likely creating confusion for seniors.
Updated Oct. 3, 2025 -
FDA seeks feedback on monitoring real-world performance of AI devices
The agency is looking for ways to detect, assess and mitigate changes to the performance of AI-enabled devices over time.
-
CommonSpirit announces initiative to address mounting headwinds, lagging finances
“We’ve worked hard, but have not made as much progress as is needed,” CFO Daniel Morissette said about the company’s 2025 financial results.
-
Humana’s Medicare Advantage star ratings slip for 2026
Humana is giving investors an early look at stars data after a CMS slip-up led some information to be inadvertantly shared online. The results are in line with expectations but still unsatisfactory, Humana said.
-
Telehealth flexibilities expire amid government shutdown
Congress failed to extend the pandemic-era telehealth policies before they lapsed on Oct. 1. Now, providers are scrambling to manage the disruption to virtual care reimbursement and access.
-
General Catalyst’s HATCo finalizes Summa Health acquisition
The $515 million deal has closed after roughly two years, creating the first hospital system owned by a venture capital company.
-
ACA premiums could rise 114% if enhanced subsidies lapse: KFF
Extending the more generous financial assistance is at the center of a funding fight between Democrats and Republicans on Capitol Hill that shut down the federal government early Wednesday.
-
HHS plans to furlough more than 40% of staff if government shuts down
A shutdown would hit the massive federal healthcare department’s agencies differently. For example, the CMS would lose 47% of its staff, while the CDC and the NIH would lose 64% and 75%, respectively.
-
Trump, Pfizer drug pricing deal short on details, possible impact
A pact to offer “most favored nation” prices to state Medicaid programs and via direct-to-consumer channels doesn’t affect those on commercial insurance or who won’t pay out of pocket.
-
Yale New Haven to pay Prospect $45M to end hospital acquisition dispute
With the agreement, the health system has officially gotten out of its 2022 deal to acquire Prospect Medical Holdings’ three Connecticut-based hospitals.
-
Medical lobbies urge Trump administration to exempt healthcare from H-1B changes
More than 50 medical groups have signed on to letters calling for healthcare workers to be exempt from new H-1B visa fees, warning the increased costs could cripple vital overseas recruitment.
-
UHS subsidiary hit with $4.7M verdict, plus damages in Nevada lawsuit
The health system was accused of improperly luring physicians away from Prime Healthcare-owned Saint Mary’s Health Network.
-
Medicare Advantage enrollment projected to fall in 2026: CMS
Nearly 1 million fewer people could sign up for the privatized Medicare plans next year, according to the CMS, marking the first time in years MA enrollment could decline.
-
UPMC patients fight to quash DOJ subpoena of gender-affirming care services
Patients are asking the health system not to comply with a subpoena seeking information about minors who received gender-affirming care services.
-
Judge vacates Medicare Advantage audit rule in win for industry
On Thursday, Texas Judge Reed O’Connor threw out a Biden-era rule that would have recouped billions of dollars in overpayments to MA plans.
-
Hospitals, doctors could lose $32B in revenue next year if ACA subsidies expire: report
It’s the latest warning about the impact to the healthcare system if the subsidies are allowed to lapse, an issue at the center of the government funding fight taking place on Capitol Hill.
-
Judge allows Ascension cyberattack class action to move forward
The judge dismissed several claims against the health system over a major ransomware attack last year, but allowed allegations of negligence to continue in court.
-
Deep Dive
Cancer patients are living longer than ever. Pain drugmakers haven’t kept up.
Decades of slow-moving research, along with broader failures of the healthcare system, have left millions of people in daily pain. Doctors fear that’s bound to continue.